FDA Inspection 900873 — AbbVie Deutschland GmbH & Co. KG
The FDA completed an inspection of AbbVie Deutschland GmbH & Co. KG on Sep 18, 2014 in Ludwigshafen. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Sep 18, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Ludwigshafen (Germany)